Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy
Lipman, I.J.; Papadopoulos, N.M.
Diseases of the Nervous System 34(1): 59-62
1973
ISSN/ISBN: 0012-3714 PMID: 4709194 Document Number: 59576
Document emailed within 1 workday
Related Documents
Darbari, A.; Bhandari, N.R.; Agrawal, B.K.; Bhambal, S.A. 1991: Cerebrospinal fluid N-acetyl neuraminic acid estimation for early diagnosis and differentiation of bacterial meningitis Indian Pediatrics 28(5): 513-519Krygowska-Wajs, A.; Szczudlik, A.; Antkiewicz-Michaluk, L.; Romańska, I.; Vetulani, J. 1997: Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients Neurologia i Neurochirurgia Polska 31(5): 875-885
Routh, J.I.; Bannow, R.E.; Fincham, R.W.; Stoll, J.L. 1971: Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy Clinical Chemistry 17(9): 867-871
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects Mayo Clinic Proceedings 46(4): 231-239
Extein, I.; Roth, R.H.; Bowers, M.B. 1974: Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa Biological Psychiatry 9(2): 161-170
Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422
Jamrozik, Z.; Królicki, L.; Kwieciński, H.; Florek, M. 1996: A cerebrospinal fluid turnover in Parkinson's disease Materia Medica Polona. Polish Journal of Medicine and Pharmacy 28(3): 79-82
Kunstmann, F.W.; Keil, E.; Tanner, E. 1972: Significance of N-acetyl-neuraminic-acid-determination for the activity evaluation of chronic progressive polyarthritis Das Deutsche Gesundheitswesen 27(1): 15-18
Cotrufo, R. 1974: Post natal development and levels of glycoproteic N-acetyl-neuraminic acid of tonic and phasic muscles in mammals Rivista di Patologia Nervosa E Mentale 95(5): 705-713
Streifler, M.; Vardi, Y.; Kesten, M.; Oberman, Z.; Herzberg, M. 1972: Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease Israel Journal of Medical Sciences 81(5): 597-601
Petit, H. 1984: Early or late dopa therapy in Parkinson's disease Presse Medicale 13(36): 2213
Muenter, M.D.; Sharpless, N.S.; Tyce, G.M. 1972: Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease Mayo Clinic Proceedings 47(6): 389-395
Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Broussolle, E. 2000: Dopa-therapy in the treatment of early stage Parkinson's disease Revue Neurologique (Paris) 156(2 Part 2): 91-97
Gauthier, G.; de Ajuriaguerra, J.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.J.; Tissot, R. 1971: Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa? La Presse Medicale 79(3): 91-92
Selby, G. 1976: The influence of previous stereotactic thalamotomy on l-dopa therapy in Parkinson's disease Proceedings of the Australian Association of Neurologists 13: 55-60
Kida, E.; Renkawek, K. 1986: Effect of serum and cerebrospinal fluid of patients with Parkinson's disease on the ultrastructural properties of rat striatum in vitro Neuropatologia Polska 24(1): 17-27
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
Cotrufo, R. 1975: Neuronal control of the glycoprotein metabolism of skeletal muscles. Reinnervation of the gastrocnemius muscle of the rabbit: reversion of the changes induced by denervation in the content of glycoprotein N-acetyl-neuraminic acid and of total proteins of the homogenate Acta Neurologica 30(2): 181-187